Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Illuccix® Receives European Approval
Contributed by:
PR Newswire
Images
Tags
Telix-ReceiveApproval
More Like This
Illuccix® Approved in the United Kingdom
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region
Telix Featured in 13 Abstracts at the Annual Congress of the European Association of Nuclear Medicine (EANM)
Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer
